一项成本控制计划对挥发性麻醉剂和神经肌肉阻滞药物使用的影响。
Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs.
作者信息
Szocik J F, Learned D W
机构信息
Department of Anesthesiology, University of Michigan, Ann Arbor.
出版信息
J Clin Anesth. 1994 Sep-Oct;6(5):378-82. doi: 10.1016/s0952-8180(05)80007-8.
STUDY OBJECTIVE
To determine the impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs.
DESIGN
Historical, controlled, retrospective analysis.
SETTING
Main operating rooms of an adult general hospital at a university medical center.
PATIENTS
All patients undergoing anesthesia between July 1991 and November 1993.
MEASUREMENTS AND MAIN RESULTS
Cost per case was determined by dividing the monthly expenditure for each class of drug by the caseload for that month. Cost per case of volatile anesthetic drugs decreased from $19.20 +/- 1.16 to $15.16 +/- 0.39 (p = 0.0034 by unpaired t-test). For neuromuscular blocking drugs, cost per case decreased from $19.67 +/- 1.35 to $12.23 +/- 0.66 (p = 0.003).
CONCLUSIONS
Concerted educational efforts can decrease the per case expenditures for both volatile anesthetic drugs and neuromuscular blocking drugs.
研究目的
确定成本控制计划对挥发性麻醉剂和神经肌肉阻滞剂使用的影响。
设计
历史性对照回顾性分析。
地点
大学医学中心一家成人综合医院的主要手术室。
患者
1991年7月至1993年11月期间所有接受麻醉的患者。
测量指标及主要结果
每例成本通过将每月每类药物的支出除以该月的病例数来确定。挥发性麻醉药物的每例成本从19.20美元±1.16美元降至15.16美元±0.39美元（未配对t检验，p = 0.0034）。对于神经肌肉阻滞剂，每例成本从19.67美元±1.35美元降至12.23美元±0.66美元（p = 0.003）。
结论
协同的教育努力可降低挥发性麻醉药物和神经肌肉阻滞剂的每例支出。
Zotero 插件